HGH Fragment 176-191 Research Guide

Full name: Human Growth Hormone Fragment 176-191

The lipolytic fragment of human growth hormone (amino acids 176-191). Retains fat-burning properties of HGH without growth-promoting or diabetogenic effects.

How HGH Fragment 176-191 Works

Mimics lipolytic action of HGH by stimulating beta-3 adrenergic receptors on adipocytes, increasing cyclic AMP and hormone-sensitive lipase activity. Does not affect IGF-1.

Dosing Protocol

• Typical dose: 250-500 mcg
• Frequency: 1-2x daily
• Duration: 8-12 weeks
• Route: Subcutaneous

Reported Benefits

• Targeted fat loss
• No IGF-1 elevation
• No glucose impairment
• No bone/organ growth effects
• Improved body composition

Potential Side Effects

• Injection site irritation
• Mild headache
• Slight drowsiness

Research Citations

1. Lipolytic effects of GH fragment 176-191 in obese mice (2018) - Produced significant fat mass reduction without affecting lean mass, glucose, or IGF-1 levels.
2. Fat metabolism modulation by GH peptide fragments (2020) - 176-191 fragment stimulated lipolysis at rates comparable to full hGH while showing no diabetogenic potential.

Related Weight Management Compounds

• AOD-9604 - Full Profile
• Semaglutide - Full Profile
• Tirzepatide - Full Profile
• Retatrutide - Full Profile
• Tesofensine - Full Profile
• CagriSema - Full Profile

View full HGH Fragment 176-191 profile with 3D molecule viewer →